STAAR SURGICAL CO
For the period ended Jan 2, 2026. Filed Mar 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Mar 3, 2026
STAA$23.87-2.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
| Common Stock Shares | Common Stock Par Value | Additional Paid-In Capital | Treasury Stock Shares | Treasury Stock | Accumulated Other Compre-hensive Income (Loss) | Accumulated Deficit | Total | |
|---|---|---|---|---|---|---|---|---|
| Balance, at December 30, 2022 | 48,212 | $482 | $404,189 | — | $— | $156 | $(68,715) | $336,112 |
| Net income | — | — | — | — | — | — | 21,347 | 21,347 |
| Other comprehensive loss | — | — | — | — | — | (4,269) | — | (4,269) |
| Common stock issued upon exercise of options | 518 | 5 | 9,667 | — | — | — | — | 9,672 |
| Stock-based compensation | — | — | 25,188 | — | — | — | — | 25,188 |
| Repurchase of employee common stock for taxes withheld | (35) | — | (2,097) | — | — | — | — | (2,097) |
| Unvested restricted stock | 14 | — | — | — | — | — | — | — |
| Vested restricted and performance stock units | 130 | 1 | — | — | — | — | — | 1 |
| Balance, at December 29, 2023 | 48,839 | 488 | 436,947 | — | — | (4,113) | (47,368) | 385,954 |
| Net loss | — | — | — | — | — | — | (20,208) | (20,208) |
| Other comprehensive loss | — | — | — | — | — | (2,918) | — | (2,918) |
| Common stock issued upon exercise of options | 315 | 3 | 7,389 | — | — | — | — | 7,392 |
| Stock-based compensation | — | — | 28,618 | — | — | — | — | 28,618 |
| Repurchase of employee common stock for taxes withheld | (44) | — | (1,505) | — | — | — | — | (1,505) |
| Unvested restricted stock | 16 | — | — | — | — | — | — | — |
| Forfeited restricted stock | (5) | — | — | — | — | — | — | — |
| Vested restricted and performance stock units | 173 | 2 | — | — | — | — | — | 2 |
| Balance, at December 27, 2024 | 49,294 | 493 | 471,449 | — | — | (7,031) | (67,576) | 397,335 |
| Net loss | — | — | — | — | — | — | (80,448) | (80,448) |
| Other comprehensive income | — | — | — | — | — | 520 | — | 520 |
| Common stock issued upon exercise of options | 221 | 2 | 3,463 | — | — | — | — | 3,465 |
| Stock-based compensation | — | — | 31,290 | — | — | — | — | 31,290 |
| Repurchase of common stock | — | — | — | (376) | (6,461) | — | — | (6,461) |
| Repurchase of employee common stock for taxes withheld | (77) | — | (1,520) | — | — | — | — | (1,520) |
| Vested restricted and performance stock units | 341 | 3 | — | — | — | — | — | 3 |
| Balance, at January 2, 2026 | 49,779 | $498 | $504,682 | (376) | $(6,461) | $(6,511) | $(148,024) | $344,184 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.